Page last updated: 2024-08-24

bromfenac and Infectious Endophthalmitis

bromfenac has been researched along with Infectious Endophthalmitis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Franklin, QJ; Kapoor, KG; Sodhi, GS; Wagner, AL1
Grzybowski, A; He, J; Hua, S; Li, W; Qi, Y; Qiao, Y; Santos, HA; Wang, W; Yao, K; Ye, Y; Zhang, H; Zhong, D; Zhou, M1
Kohnen, T1
Bansal, R; Gupta, A; Pandav, SS; Ram, J; Sahu, S1
Kato, S; Maruyama, Y; Miyai, T; Miyanaga, M; Miyata, K; Nejima, R1
Attar, M; Borbridge, L; Galindo, D; Hollander, DA; Nguyen, C; Patel, M; Schiffman, RM; Villanueva, L; Waterbury, LD1
Donnenfeld, A; Donnenfeld, ED1

Reviews

1 review(s) available for bromfenac and Infectious Endophthalmitis

ArticleYear
Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug.
    International ophthalmology clinics, 2006,Fall, Volume: 46, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Drug Administration Schedule; Endophthalmitis; Humans; Ophthalmic Solutions; Treatment Outcome

2006

Trials

2 trial(s) available for bromfenac and Infectious Endophthalmitis

ArticleYear
Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
    Journal of cataract and refractive surgery, 2015, Volume: 41, Issue:10

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Endophthalmitis; Female; Humans; Intraocular Pressure; Ketorolac; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Photometry; Postoperative Complications; Prospective Studies; Visual Acuity

2015
Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery.
    Acta ophthalmologica, 2009, Volume: 87, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Betamethasone; Bromobenzenes; Cataract Extraction; Cornea; Drug Therapy, Combination; Endophthalmitis; Endothelium, Corneal; Female; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Postoperative Period; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity

2009

Other Studies

4 other study(ies) available for bromfenac and Infectious Endophthalmitis

ArticleYear
Successful Clinical Outcome of Vancomycin-induced Hemorrhagic Occlusive Retinal Vasculitis.
    Ocular immunology and inflammation, 2021, May-19, Volume: 29, Issue:4

    Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Benzophenones; Bromobenzenes; Cataract Extraction; Drug Combinations; Endophthalmitis; Eye Infections, Bacterial; Female; Fluorescein Angiography; Glucocorticoids; Humans; Prednisone; Retinal Hemorrhage; Retinal Vasculitis; Tomography, Optical Coherence; Valacyclovir; Vancomycin

2021
Mild temperature photothermal assisted anti-bacterial and anti-inflammatory nanosystem for synergistic treatment of post-cataract surgery endophthalmitis.
    Theranostics, 2020, Volume: 10, Issue:19

    Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Benzophenones; Bromobenzenes; Cataract Extraction; Copper; Disease Models, Animal; Drug Synergism; Drug Therapy; Endophthalmitis; Gold; Humans; Metal Nanoparticles; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Photothermal Therapy; Rabbits; Silver; Treatment Outcome

2020
Treating inflammation after lens surgery.
    Journal of cataract and refractive surgery, 2015, Volume: 41, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Endophthalmitis; Humans; Ketorolac; Phacoemulsification; Phenylacetates; Postoperative Complications

2015
Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2011, Volume: 27, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Benzophenones; Bromobenzenes; Dextrans; Dinoprostone; Endophthalmitis; Eye; Female; Fluorescein-5-isothiocyanate; Ketorolac; Lipopolysaccharides; Prostaglandin-Endoperoxide Synthases; Rabbits

2011